Sanofi rare disease med clinches world-first nod in Japan, presaging potential approvals in US, Europe
March 28, 2022FDA halts use of GlaxoSmithKline and Vir’s COVID-19 drug Xevudy in 8 northeast states
March 28, 2022UCB wins wider Fintepla label, setting up showdown with Jazz’s Epidiolex
esagonowsky
Mon, 03/28/2022 – 08:49
